The RANK/RANKL/OPG triad in cancer-induced bone diseases

By Dougall William   Chaisson Michelle  

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 541-549

Springer Publishing Company

Access to resources Recommend Favorite

The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma (Review)

By          

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 803-809

Spandidos Publications

Access to resources Recommend Favorite

Agents Targeting Prostate Cancer Bone Metastasis

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1079-1088

Bentham Science Publishers

Access to resources Recommend Favorite

Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton

By Mountzios Giannis   Dimopoulos Meletios-Athanassios   Bamias Aristotelis   Papadopoulos George   Kastritis Efstathios   Syrigos Konstantinos   Pavlakis George   Terpos Evangelos  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 221-229

Informa Healthcare

Access to resources Recommend Favorite

The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients

By        

Molecular Medicine Reports, Vol. 7, Iss. 4, 2013-01 ,pp. : 1169-1172

Spandidos Publications

Access to resources Recommend Favorite